96 related articles for article (PubMed ID: 38443991)
1. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J
Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213
[TBL] [Abstract][Full Text] [Related]
2. ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma.
Xu L; Barrett JG; Peng J; Li S; Messadi D; Hu S
Curr Oncol; 2024 Mar; 31(3):1311-1322. PubMed ID: 38534932
[TBL] [Abstract][Full Text] [Related]
3. The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genes.
Yu J; Yang Y; Zhou R; Tao Y; Zhu F; Jiao W; Zhang Z; Ji T; Li T; Fang F; Xie Y; Wu D; Zhuo R; Li X; Chen Y; Yin H; Wang J; Pan J
Carcinogenesis; 2024 Jun; 45(6):424-435. PubMed ID: 38302114
[TBL] [Abstract][Full Text] [Related]
4. Integrating bulk and single-cell sequencing reveals metastasis-associated CAFs in head and neck squamous cell carcinoma.
Yao Y; Tian G; Zhang J; Zhang S; Liu X; Hou J
Life Sci; 2024 Jun; ():122768. PubMed ID: 38851417
[TBL] [Abstract][Full Text] [Related]
5. Intron 1-Mediated Regulation of
Jameson NM; Ma J; Benitez J; Izurieta A; Han JY; Mendez R; Parisian A; Furnari F
Mol Cancer Res; 2019 Nov; 17(11):2208-2220. PubMed ID: 31444232
[TBL] [Abstract][Full Text] [Related]
6. KIF2C is a critical regulator for malignant progression of head and neck squamous cell carcinoma.
Zhu H; Bao Y; Dou X; Zuo X; Ye J; Ma H; Bu Y; Wang Y; Zhu J
Am J Cancer Res; 2024; 14(5):2538-2554. PubMed ID: 38859848
[TBL] [Abstract][Full Text] [Related]
7. Super-enhancer-driven ameboidal-type cell migration-related MMP14 expression in tongue squamous cell carcinoma switched by BATF and ATF3.
Shi Z; Wang R; Huang J; Qian Q; Hu M; Zhang H; Feng L; Gu H; Wang Y
J Pharm Pharmacol; 2024 Jun; ():. PubMed ID: 38836550
[TBL] [Abstract][Full Text] [Related]
8. Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC.
Xiang Y; Li F; Wang L; Zheng A; Zuo J; Li M; Wang Y; Xu Y; Chen C; Chen S; Xiao B; Tao Z
Oncol Lett; 2017 Apr; 13(4):2237-2243. PubMed ID: 28454386
[TBL] [Abstract][Full Text] [Related]
9. Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.
Chen YL; Zhuo R; Sun LC; Tao YF; Li G; Zhu F; Xu YY; Wang JW; Li ZH; Yu JJ; Yin HL; Wu D; Li XL; Fang F; Xie Y; Hu YZ; Wang HR; Yang C; Shi L; Wang XD; Zhang ZM; Pan J
Neuro Oncol; 2024 Jun; ():. PubMed ID: 38864832
[TBL] [Abstract][Full Text] [Related]
10. circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA.
Okholm TLH; Kamstrup AB; Nielsen MM; Hollensen AK; Graversgaard ML; Sørensen MH; Kristensen LS; Vang S; Park SS; Yeo GW; Dyrskjøt L; Kjems J; Pedersen JS; Damgaard CK
bioRxiv; 2024 Jun; ():. PubMed ID: 37745562
[TBL] [Abstract][Full Text] [Related]
11. An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma.
Oyelakin A; Sosa J; Nayak KB; Glathar A; Gluck C; Sethi I; Tsompana M; Nowak N; Buck M; Romano RA; Sinha S
NAR Cancer; 2023 Sep; 5(3):zcad038. PubMed ID: 37492374
[TBL] [Abstract][Full Text] [Related]
12. Phase-separated super-enhancers confer an innate radioresistance on genomic DNA.
Matsumoto K; Ikliptikawati DK; Makiyama K; Mochizuki K; Tobita M; Kobayashi I; Voon DC; Lim K; Ogawa K; Kashiwakura I; Suzuki HI; Yoshino H; Wong RW; Hazawa M
J Radiat Res; 2024 Jun; ():. PubMed ID: 38874522
[TBL] [Abstract][Full Text] [Related]
13. IGF2BP2-Shox2 axis regulates hippocampal-neuronal senescence to alleviate microgravity-induced recognition disturbance.
Zhao Y; Ji G; Zhou S; Cai S; Li K; Zhang W; Zhang C; Yan N; Zhang S; Li X; Song B; Qu L
iScience; 2024 Jun; 27(6):109917. PubMed ID: 38812544
[TBL] [Abstract][Full Text] [Related]
14. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J
J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
16. m
Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J
Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589
[TBL] [Abstract][Full Text] [Related]
17. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
[TBL] [Abstract][Full Text] [Related]
18. FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program.
Zhang M; Hoyle RG; Ma Z; Sun B; Cai W; Cai H; Xie N; Zhang Y; Hou J; Liu X; Chen D; Kellogg GE; Harada H; Sun Y; Wang C; Li J
Mol Ther; 2021 Aug; 29(8):2583-2600. PubMed ID: 33794365
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer.
Yao Z; Song P; Jiao W
Front Pharmacol; 2024; 15():1383580. PubMed ID: 38681203
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
